New Report Analyses the Global Market for Insulin Products

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report providing a competitor analysis in the development pipeline of novel insulin-based products for treatment of diabetes.
By: Jonna Dagliden
 
Oct. 30, 2008 - PRLog -- Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has added a new report providing a competitor analysis in the development pipeline of novel insulin-based products for treatment of type 1 and 2 diabetes.

“Insulin: Competitor Analysis” which is available at http://www.piribo.com/search/results.html?k=++LME060 reports that three companies dominate the worldwide insulin market, but experience more and more competition in volume sales of insulin by local manufacturers in off-patent countries, especially in China, India and Russia.

The first Indian company is conducting clinical trials in the US with its rhu insulin and even plans to develop and launch a biosimilar insulin analog in the Western countries upon patent expiry in 2014. Three companies in off-patent countries have locally produced insulin analogs either in the market or in pre-registration phases.

Authors of the report note that the next generations of insulin will be "tailored" insulin and oral insulin. They further note that after the failure of inhaled insulin (only one clinical stage project left), most of the R&D efforts are now made on oral insulin products.

The pipeline of oral insulin shows at least seven different oral insulin formulations in clinical development, and at least six in preclinical development. The first oral insulin product is already marketed and in advanced registration in many countries. Further six different projects with non-injectable drug delivery of insulin are in clinical development: intranasal, transdermal and rectal application.

The report “Insulin: Competitor Analysis” is available in pdf format from Piribo: http://www.piribo.com/publications/diseases_conditions/di...

Piribo product ID: LME060

# # #

About Piribo.
Piribo (http://www.piribo.com/publications/diseases_conditions/di...) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 10,000 English language titles including, market reports, studies and books and is the UK's largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.
End
Source:Jonna Dagliden
Email:Contact Author
Zip:SE1 3LJ
Tags:Diabetes, Type 1, Type 2, Insulin
Industry:Medical
Location:London City - London, Greater - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Piribo News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share